Estados financieros detallados de Perspective Therapeutics, Inc. (CATX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -419.4%, margen operativo -342.2%, margen neto -318.1%.
Al precio actual de $2.70, CATX presenta beneficios negativos (P/E no significativo) y un ROE del -41.56%. La capitalización bursátil es de $308M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $4.8M | $5.9M | $7.3M | $9.7M | $10.1M | $10.8M | $5.4M | $1.4M | $1.5M | 0 |
| Coste de Ventas | $3.9M | $4.1M | $4.3M | $4.6M | $4.9M | $6.2M | $3.0M | 0 | $2.3M | 0 |
| Beneficio Bruto | $838000 | $1.8M | $3.0M | $5.1M | $5.1M | $4.6M | $2.4M | $1.4M | -$852000 | 0 |
| I+D | $965000 | $1.7M | $1.5M | $1.1M | $1.4M | $2.6M | $1.8M | $21.3M | $39.3M | $84.2M |
| Generales y Administrativos | $6.2M | $6.8M | $6.9M | $7.5M | $7.1M | $9.4M | $9.4M | $21.1M | $26.6M | $30.2M |
| Gastos Operativos | $7.1M | $8.6M | $8.3M | $8.6M | $8.6M | $12.0M | $11.5M | $42.4M | $65.9M | $113.6M |
| Beneficio Operativo | -$6.3M | -$6.7M | -$5.3M | -$3.5M | -$3.4M | -$7.4M | -$9.1M | -$40.9M | -$66.8M | -$113.6M |
| EBITDA | -$6.2M | -$6.7M | -$5.1M | -$3.5M | -$3.4M | -$7.1M | -$8.5M | -$40.0M | -$64.5M | -$100.8M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $84000 | $48000 | $376000 |
| Beneficio Antes de Impuestos | -$6.2M | -$6.7M | -$5.1M | -$3.4M | -$3.4M | -$7.3M | -$8.5M | -$40.1M | -$80.4M | -$104.4M |
| Impuestos | -$145000 | -$29000 | -$294000 | -$177000 | -$199000 | 0 | 0 | -$2.7M | -$2.1M | -$793000 |
| Beneficio Neto | -$6.2M | -$6.7M | -$4.8M | -$3.3M | -$3.2M | -$7.3M | -$10.8M | -$46.5M | -$79.3M | -$103.1M |
| BPA | $-0.11 | $-0.12 | $-0.07 | $-0.05 | $-0.06 | $-0.50 | $-0.60 | $-0.85 | $-1.23 | $-1.40 |
| BPA Diluido | $-0.11 | $-0.12 | $-0.07 | $-0.05 | $-0.06 | $-0.50 | $-0.60 | $-0.85 | $-1.23 | $-1.40 |
| Acciones en Circulación (Diluidas) | $55.0M | $55.2M | $67.0M | $67.6M | $54.9M | $14.2M | $14.2M | $54.9M | $64.4M | $73.8M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.9M | $2.6M | $5.3M | $2.4M | $9.6M | $55.9M | $21.0M | $9.2M | $61.6M | $30.6M |
| Inversiones a Corto | $3.0M | $825000 | 0 | 0 | 0 | 0 | $22.8M | 0 | $165.3M | $114.1M |
| Cuentas por Cobrar | $726000 | $1.2M | $1.2M | $2.0M | $1.7M | $1.6M | $1.4M | $1.2M | $116000 | $1.0M |
| Inventario | $323000 | $516000 | $530000 | $645000 | $665000 | $1.4M | $1.4M | 0 | 0 | 0 |
| Activos Corrientes | $10.3M | $5.5M | $7.3M | $5.5M | $12.3M | $59.3M | $53.2M | $16.8M | $231.2M | $148.4M |
| Inmovilizado Material | $1.1M | $1.3M | $1.6M | $2.7M | $2.7M | $2.5M | $371000 | $6.3M | $59.5M | $78.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.1M | 0 | 0 |
| Activos Intangibles | $230000 | $198000 | $162000 | $138000 | $130000 | $107000 | $25000 | $50.4M | $50.0M | $40.0M |
| Activos Totales | $12.3M | $7.5M | $9.4M | $8.7M | $15.5M | $64.4M | $58.1M | $97.9M | $341.1M | $267.0M |
| Cuentas por Pagar | $630000 | $1.4M | $683000 | $654000 | $494000 | $966000 | $1.5M | $6.9M | $10.3M | $20.5M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $49000 | $52000 | $56000 |
| Pasivos Corrientes | $1.1M | $1.8M | $1.1M | $1.6M | $1.3M | $2.3M | $3.1M | $15.7M | $18.2M | $28.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.7M | $1.6M | $1.6M |
| Pasivos Totales | $1.7M | $2.4M | $1.7M | $3.0M | $2.7M | $3.2M | $3.4M | $22.7M | $50.4M | $59.9M |
| Reservas | -$72.6M | -$79.3M | -$84.5M | -$87.9M | -$89.5M | -$98.6M | -$105.9M | -$152.4M | -$231.7M | -$334.8M |
| Patrimonio Neto | $10.6M | $5.0M | $7.7M | $5.7M | $12.8M | $61.3M | $54.6M | $75.2M | $290.7M | $207.0M |
| Deuda Total | 0 | 0 | 0 | $1.0M | $897000 | $524000 | $524000 | $2.6M | $4.1M | $3.3M |
| Deuda Neta | -$9.0M | -$3.4M | -$5.3M | -$1.4M | -$8.7M | -$55.4M | -$43.2M | -$6.7M | -$222.9M | -$141.5M |
| Capital Circulante | $9.2M | $3.6M | $6.2M | $3.9M | $11.0M | $57.1M | $50.1M | $1.2M | $212.9M | $119.7M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$6.2M | -$6.7M | -$5.1M | -$3.4M | -$3.4M | -$7.3M | -$10.8M | -$46.5M | -$79.3M | -$103.1M |
| Amortizaciones | $68000 | $80000 | $136000 | $147000 | $149000 | $248000 | $324000 | $986000 | $2.3M | $3.3M |
| Compensación en Acciones | $372000 | $607000 | $420000 | $495000 | $386000 | $1.1M | $807000 | $3.7M | $5.4M | $9.0M |
| Cambio en Capital Circulante | $17000 | $222000 | -$518000 | -$835000 | -$67000 | -$1.9M | -$1.7M | $2.9M | $31.8M | $1.7M |
| Flujo de Caja Operativo | -$5.7M | -$5.7M | -$5.0M | -$3.6M | -$2.8M | -$7.7M | -$10.4M | -$36.9M | -$18.3M | -$82.5M |
| Inversiones (CapEx) | -$549000 | -$337000 | -$444000 | -$273000 | -$381000 | -$266000 | -$282000 | -$1.1M | -$54.4M | -$12.7M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.7M | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | -$11000 | -$11000 | -$11000 | -$11000 | -$9000 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$6.3M | -$6.0M | -$5.5M | -$3.9M | -$3.2M | -$8.0M | -$10.7M | -$38.0M | -$72.7M | -$95.2M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +24.4% | +23.5% | +32.3% | +3.9% | +7.4% | -49.8% | -73.5% | +1.4% | -100.0% | |
| Crecimiento Beneficio Neto (anual) | -8.7% | +27.6% | +32.6% | +2.5% | -128.1% | -48.0% | -332.2% | -70.5% | -30.1% | |
| Crecimiento BPA (anual) | -9.1% | +39.8% | +33.1% | -20.0% | -760.6% | -20.0% | -41.7% | -44.7% | -13.8% | |
| Cambio en Acciones (anual) | +0.3% | +21.5% | +0.8% | -18.8% | -74.1% | +0.1% | +286.5% | +17.3% | +14.6% | |
| Crecimiento FCF (anual) | +3.4% | +9.2% | +28.7% | +17.8% | -147.9% | -33.9% | -255.6% | -91.4% | -31.0% | |
| Margen Bruto | 17.6% | 31.1% | 41.7% | 52.9% | 50.9% | 42.8% | 43.7% | 100.0% | -58.6% | |
| Margen Operativo | -132.5% | -113.6% | -72.2% | -35.9% | -34.2% | -68.5% | -168.1% | -2855.0% | -4594.0% | |
| Margen EBITDA | -130.0% | -113.1% | -70.3% | -35.9% | -34.1% | -66.2% | -156.6% | -2786.6% | -4435.4% | |
| Margen Neto | -129.4% | -113.1% | -66.3% | -33.8% | -31.7% | -67.4% | -198.7% | -3243.2% | -5452.5% | |
| Margen FCF | -131.5% | -102.1% | -75.1% | -40.4% | -32.0% | -73.9% | -197.3% | -2648.9% | -5000.6% | |
| Tasa Impositiva Efectiva | 2.4% | 0.4% | 5.7% | 5.1% | 5.9% | -0.0% | -0.0% | 6.6% | 2.6% | 0.8% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.11 | $-0.11 | $-0.08 | $-0.06 | $-0.06 | $-0.56 | $-0.75 | $-0.69 | $-1.13 | $-1.29 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $55.0M | $55.2M | $67.0M | $67.6M | $54.9M | $14.2M | $18.0M | $54.9M | $64.4M | $73.8M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -41.56% |
| Rentabilidad sobre capital invertido | -34.94% |
| Rentabilidad sobre activos | -29.70% |
| Margen bruto | -419.40% |
| Margen operativo | -34216.39% |
| Margen neto | -31812.57% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 6.61 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -56.82 | -37.50 | -56.71 | -114.88 | -137.35 | -6.18 | -4.12 | -4.73 | -2.59 | -1.96 |
| P/VC | 32.43 | 49.35 | 35.79 | 65.68 | 34.30 | 0.72 | 0.81 | 2.94 | 0.71 | 0.98 |
| P/V | 72.22 | 41.91 | 37.58 | 38.83 | 43.58 | 4.06 | 8.22 | 153.92 | 141.35 | 0.00 |
| Margen Bruto | 17.6% | 31.1% | 41.7% | 52.9% | 50.9% | 42.8% | 43.7% | 100.0% | -58.6% | 0.0% |
| Margen Operativo | -132.5% | -113.6% | -72.2% | -35.9% | -34.2% | -68.5% | -168.1% | -2855.0% | -4594.0% | 0.0% |
| Margen Neto | -129.4% | -113.1% | -66.3% | -33.8% | -31.7% | -67.4% | -198.7% | -3243.2% | -5452.5% | 0.0% |
Empresas relacionadas: AVR · ELMD · HSDT · IVVD · MXCT · NNOX · NYXH
Explorar sector: Healthcare · Medical - Devices
Más secciones de CATX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones